These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37587799)

  • 1. Psychological Burden and Willingness to Pay Among Korean Rosacea Patients and Their Association With Rosacea Phenotype and Severity: A Multi-Center Cross-Sectional Study.
    Woo YR; Kim S; Cho SH; Kim HS
    J Cutan Med Surg; 2023 Nov; 27(6):601-607. PubMed ID: 37587799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Related Quality of Life of Rosacea Patients in China Assessed by Dermatology Life Quality Index and Willingness to Pay.
    Huang Y; Yan S; Xie H; Wang B; Zhao Z; Huang Y; Li J
    Patient Prefer Adherence; 2022; 16():659-670. PubMed ID: 35283624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay and quality of life in patients with rosacea.
    Beikert FC; Langenbruch AK; Radtke MA; Augustin M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):734-8. PubMed ID: 22583164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness-to-Pay and Benefit-Cost Analysis of IPL for Rosacea Treatment: A Cross-Sectional Study in China.
    Deng Q; Zhang SP; Deng YX; Liu FF; Shi W; Xie HF; Xiao Y; Huang YX; Li J
    Patient Prefer Adherence; 2020; 14():1843-1852. PubMed ID: 33116428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of skin disorders associated with facial discoloration on quality of life: Novel insights explaining discordance between life quality scores and willingness to pay.
    Yang TT; Lan CE
    J Cosmet Dermatol; 2022 Jul; 21(7):3053-3058. PubMed ID: 34706154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness-to-Pay and Benefit-Cost Analysis of Botulinum Toxin for the Treatment of Rosacea in China: Findings from a Web-Based Survey.
    Yang X; Ouyang Y; Deng Y; Xiao Y; Tang Y; Jian D; Li J; Xie H; Huang Y
    Patient Prefer Adherence; 2021; 15():1197-1205. PubMed ID: 34113082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay and quality of life in patients with atopic dermatitis.
    Beikert FC; Langenbruch AK; Radtke MA; Kornek T; Purwins S; Augustin M
    Arch Dermatol Res; 2014 Apr; 306(3):279-86. PubMed ID: 23982630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the willingness-to-pay for cancer treatment in Korean metastatic breast cancer patients: a multicenter, cross-sectional study.
    Oh DY; Crawford B; Kim SB; Chung HC; McDonald J; Lee SY; Ko SK; Ro J
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):282-91. PubMed ID: 22898238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dermatology life quality index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients.
    Wu Y; Fu C; Zhang W; Li C; Zhang J
    Psychol Health Med; 2018 Apr; 23(4):369-374. PubMed ID: 28797174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing willingness-to-pay and time-trade-off as the measures of burden of psoriasis: A pooled analysis of community, hospital, and web-based samples in China.
    Shen M; Xiao H; Zhu W; Lu Y; Jing D; Kuang Y; Li M; Guan X; Sheng P; Su J; Chen X; Xiao Y
    J Dermatol; 2022 Nov; 49(11):1131-1138. PubMed ID: 35906766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Willingness to pay and quality of life in patients with pruritic skin disorders.
    Stefanidou M; Evangelou G; Kontodimopoulos N; Koumaki D; Krueger-Krasagakis SE; Yosipovitch G; Krasagakis K
    Arch Dermatol Res; 2019 Apr; 311(3):221-230. PubMed ID: 30788568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients?
    Schiffner R; Schiffner-Rohe J; Gerstenhauer M; Hofstädter F; Landthaler M; Stolz W
    Br J Dermatol; 2003 Jun; 148(6):1153-60. PubMed ID: 12828743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Vitiligo on Life Quality of Patients: Assessment of Currently Available Tools.
    Yang TT; Lee CH; Lan CE
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cross-Sectional Study on the Relationship Between Rosacea Severity and Quality of Life or Psychological State.
    Yang F; Zhang Q; Song D; Liu X; Wang L; Jiang X
    Clin Cosmet Investig Dermatol; 2022; 15():2807-2816. PubMed ID: 36573169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring melasma patients' quality of life using willingness to pay and time trade-off methods in Thai population.
    Leeyaphan C; Wanitphakdeedecha R; Manuskiatti W; Kulthanan K
    BMC Dermatol; 2011 Dec; 11():16. PubMed ID: 22182399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerns and Treatment Satisfaction in Patients Being Treated With Azelaic Acid Foam for Rosacea.
    Williamson T; Cameron J; McLeod K; Turner B; Quillen A; LaRose A; Lott J; Gaiser A
    J Drugs Dermatol; 2019 Apr; 18(4):381-386. PubMed ID: 31013011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China.
    Chen M; Deng Z; Huang Y; Li J
    Front Psychiatry; 2021; 12():659171. PubMed ID: 34220573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom severity and psychological sequelae in rosacea: results of a survey.
    Böhm D; Schwanitz P; Stock Gissendanner S; Schmid-Ott G; Schulz W
    Psychol Health Med; 2014; 19(5):586-91. PubMed ID: 24088195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.